Product Information

CARBAMAZEPINE ER 400 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.8136 per EA under NDC 16571068201. Its NADAC has been published 311 times since Dec 9, 2020.

FDA first approved this application on Apr 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 400 MG TABLET

CARBAMAZEPINE
$0.8136per EA

Strength

400 mg/1

NDC

16571068201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211623

FDA Approved

4/24/2020

TE Code

AB

On Market Since

4/24/2020

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 400 MG TABLET has been published 311 times since Dec 9, 2020, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8136 per EA
All-time high$2.2973 (Apr 14, 2021)
All-time low$0.5156 (Nov 20, 2024)
52-week high$0.8136
52-week low$0.5655
Median price$1.0183
Average price$1.1767
Largest weekly change+78.1% (May 17, 2023)
Weeks tracked311
Tracking sinceDec 9, 2020

Price History

1W

+14.9%

1M

+24.6%

3M

+32.7%

6M

+35.4%

1Y

+11.9%

3Y

-29.3%

5Y

-60.5%

All

-63.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 400 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.8136 per EA (NDC 16571068201), effective Nov 18, 2026.

How has the price of CARBAMAZEPINE ER 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has declined 63.8%. It has been tracked across 311 weekly CMS publications since Dec 9, 2020.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 400 MG TABLET?

Since Dec 9, 2020, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has ranged from a low of $0.5156 (Nov 20, 2024) to a high of $2.2973 (Apr 14, 2021), with a median of $1.0183 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 400 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE ER 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBAMAZEPINE ER 400 MG TABLET?

CARBAMAZEPINE ER 400 MG TABLET (NDC 16571068201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.